Actively Recruiting

Phase Not Applicable
Age: 13Years - 17Years
All Genders
NCT06864208

Addressing Weight Bias Internalization to Improve Adolescent Weight Management Outcomes: Randomized Pilot Trial

Led by The Miriam Hospital · Updated on 2025-09-24

64

Participants Needed

1

Research Sites

96 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Weight stigma and weight bias internalization (WBI) are common among adolescents at higher weight statuses. WBI is associated with negative physical and mental health outcomes. The current study aims to test an intervention for weight stigma and WBI combined with an evidence-based adolescent weight management program. Eligible adolescents (13-17) will be assigned by chance to one of two groups: 1) a 4-week intervention focused on weight stigma and WBI followed by a 16-week behavioral weight management program; or 2) a 4-week health information control (to include non-weight-related health promotion topics such as smoking and skin cancer prevention) followed by the same 16-week weight management program but without the WBI and weight stigma content. Study outcomes will be assessed at the 4-week and post-treatment (20 week) timepoints.

CONDITIONS

Official Title

Addressing Weight Bias Internalization to Improve Adolescent Weight Management Outcomes: Randomized Pilot Trial

Who Can Participate

Age: 13Years - 17Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Speak English
  • Between 13 and 17 years old
  • BMI at or above the 95th percentile for age and sex
  • Have at least one caregiver available to provide consent and participate in sessions
  • Agree to participate in the study
Not Eligible

You will not qualify if you...

  • Cognitive impairment or developmental delay that affects participation in group settings
  • Currently in a weight management program or recent weight loss of 5% or more of body weight
  • Medical condition affecting weight or preventing study participation
  • Current use of glucagon-like peptide-1 (GLP-1) receptor agonists

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

The Miriam Hospital

Providence, Rhode Island, United States, 02903

Actively Recruiting

Loading map...

Research Team

K

Katherine Darling, PhD

CONTACT

A

Andrea M Grenga, BA

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here